You are here

Article Text

Article menu
LETTERS TO THE EDITOR
Mesalazine as a maintenance treatment in Crohn’s disease
  1. L R SUTHERLAND,
  2. A H STEINHART
  1. Department of Medicine,
  2. University of Calgary,
  3. 3330 Hospital Drive NW,
  4. Calgary, AB, T2N 4N1,
  5. Canada

https://doi.org/10.1136/gut.42.1.143-c

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Editor,—We read with interest the occasional viewpoint by Sahmoud and Mary (Gut1997;40:284–5). As is too often the case in such reviews, the authors have failed to identify all of the relevant literature pertinent to the topic: the maintenance of remission or prevention of recurrence of Crohn’s disease. For example, with regard to azathioprine, rather than two trials of treatment, actually six trials (including the NCCDS Parts I …

    View Full Text